Cargando…
Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
Animal and human mechanistic studies have consistently shown an association between obesity and Alzheimer’s disease (AD). AD, a degenerative brain disease, is the most common cause of dementia and is characterized by the presence of extracellular amyloid beta (Aβ) plaques and intracellular neurofibr...
Autores principales: | Kim, Jong Youl, Barua, Sumit, Jeong, Ye Jun, Lee, Jong Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504582/ https://www.ncbi.nlm.nih.gov/pubmed/32899357 http://dx.doi.org/10.3390/ijms21176419 |
Ejemplares similares
-
Role of agmatine in the application of neural progenitor cell in central nervous system diseases: therapeutic potentials and effects
por: Kosonen, Renée, et al.
Publicado: (2021) -
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
por: Sim, A Young, et al.
Publicado: (2021) -
Adiponectin as a new paradigm for approaching Alzheimer's disease
por: Song, Juhyun, et al.
Publicado: (2013) -
The role of NOX inhibitors in neurodegenerative diseases
por: Barua, Sumit, et al.
Publicado: (2019) -
Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020)